The role of non-genomic actions of progesterone and its membrane receptor agonist in ovarian cancer cell death.
Takahiro KoyanagiYasushi SagaYoshifumi TakahashiKohei TamuraTakahiro YoshibaSuzuyo TakahashiAkiyo TaneichiYuji TakeiHiroaki MizukamiHiroyuki FujiwaraPublished in: Cancer reports (Hoboken, N.J.) (2023)
Progesterone and MPA exhibited a rapid cytocidal effect on PR-negative ovarian cancer cells through non-genomic action. Progesterone and MPA could be novel adjuvant therapies for ovarian cancer.